Healthcare & Life Sciences
Re-Aim Therapeutics
seed
seed
Stage
1
Investors
About
Re-Aim Therapeutics is a biotechnology company focused on developing pre-clinical stage therapeutic candidates.
Explore Re-Aim Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.